Infectious Diseases Clinic, Azienda Sanitaria Universitaria del Friuli Centrale (ASUFC), Udine, Italy.
First Division of Infectious Diseases, Cotugno Hospital, Azienda Ospedaliera Dei Colli, Napoli, Italy, retired.
New Microbiol. 2023 May;46(2):95-119.
Although progress has led to a drop in infections, meningitis still represents a threat worldwide, affecting some areas more than others. As a medical emergency, it requires prompt recognition and treatment. Moreover, diagnosis relies on invasive methods, while representing a tug-of-war with timely therapeutic interventions, since delays are burdened by mortality and life-long sequalae. While counterbalancing the overuse of antimicrobials, it is imperative to assess correct interventions in order to optimize treatments and reduce negative outcomes. Because the drop in mortality and consequences has been consistent, although not as impactful as with other vaccine-preventable diseases, the WHO has traced a roadmap detailing actions to reduce the meningitis burden by 2030. There are currently no updated guidelines, whereas novel diagnostic methods as well as pharmacological interventions are increasing, along with the shifting epidemiology. In light of the above, this paper wishes to summarize existing data and evidences and suggest potential novel solutions to a complex problem.
尽管已有进展导致感染率下降,但脑膜炎在全球范围内仍构成威胁,一些地区比其他地区受影响更严重。作为一种医疗急症,它需要及时识别和治疗。此外,诊断依赖于有创方法,而这与及时的治疗干预存在拉锯战,因为延迟会导致死亡率和终身后遗症增加。虽然需要平衡抗生素的过度使用,但评估正确的干预措施至关重要,以优化治疗并减少不良后果。尽管与其他可通过疫苗预防的疾病相比,其死亡率和后果的降低并不明显,但全球卫生组织已制定了路线图,详细说明了到 2030 年降低脑膜炎负担的措施。目前尚无更新的指南,而新的诊断方法和药物干预措施正在增加,同时流行病学也在变化。有鉴于此,本文旨在总结现有数据和证据,并为这一复杂问题提出潜在的新解决方案。